Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection

Transplantation

Volumn 88, Issue 2, 2009, Pages 180-187

  Hamrah, Pedram ^a,b   Haskova, Zdenka ^a   Taylor, Andrew W ^a   Zhang, Qiang ^a   Ksander, Bruce R ^a   Dana, M Reza ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Allograft rejection; Alpha melanocyte stimulating hormone; Corneal transplantation; Dendritic cells; Neuropeptide

Indexed keywords

ALPHA INTERMEDIN; GAMMA INTERFERON; INTERLEUKIN 2;

ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DELAYED HYPERSENSITIVITY; DRUG EFFICACY; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

ALPHA-MSH; ANIMALS; CORNEAL TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; INTERFERON-GAMMA; INTERLEUKIN-2; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUROPEPTIDES; TRANSPLANTATION, HOMOLOGOUS;

EID: 68249109680     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ac11ea     Document Type: Article

References (45)

1. The Collaborative Corneal Transplantation Studies Research Group. The Collaborative Corneal Transplantation Studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992; 110: 1392.
2. Dana MR, Qian Y, Hamrah P. Twenty-five-year panorama of corneal immunology: Emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea 2000; 19: 625.
3. Hamrah P, Djalilian AR, Stulting RD. Immunologically high-risk penetrating keratoplasty. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea, vol. 2. Mosby, St. Louis 2005, p 1619.
4. Hill JC. The use of cyclosporine in high-risk keratoplasty. Am J Ophthalmol 1989; 107: 506.
5. Raizman M. Corticosteroid therapy of eye disease. Fifty years later. Arch Ophthalmol 1996; 114: 1000.
6. Eberle AN. The melanotropins. S. Karger, Basel 1988.
7. Gonzalez-Rey E, Chorny A, Delgado M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol 2007; 7: 52.
8. Cutuli M, Cristiani S, Lipton JM, et al. Antimicrobial effects of α-MSH peptides. J Leukoc Biol 2000; 67: 233.
9. Taylor AW, Streilein JW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 1992; 11: 1199.
10. Lipton JM, Catania A. Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol Today 1997; 18: 140.
11. Taylor AW. Modulation of regulatory T cell immunity by the neuropeptide alpha-melanocyte stimulating hormone. Cell Mol Biol 2003; 49: 143.
12. Bohm M, Schulte U, Kalden H, et al. Alpha-melanocyte-stimulating hormone modulates activation of NF-kappa B and AP-1 and secretion of interleukin-8 in human dermal fibroblasts. Ann N Y Acad Sci 1999; 885: 277.
13. Becher E, Mahnke K, Brzoska T, et al. Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R. Ann N Y Acad Sci 1999; 885: 188.
14. Morandini R, Boeynaems JM, Hadley SJ, et al. Modulation of ICAM-1 expression by α-MSH in human melanoma cells and melanocytes. J Cell Physiol 1998; 175: 276.
15. Watanabe T, Hiltz ME, Catania A, et al. Inhibition of IL-1β-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide α-MSH. Brain Res Bull 1993; 32: 311.
16. Wikberg JE, Mucience R, Mandrika I, et al. New aspects on the melanocortins and their receptors. Pharmacol Res 2000; 42: 393.
17. Neumann Andersen G, Nagaeva O, Mandrika I, et al. MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions. Clin Exp Immunol 2001; 126: 441.
18. Taylor AW, Yee DG, Nishida T, et al. Neuropeptide regulation of immunity. The immunosuppressive activity of α-melanocyte stimulating hormone (α-MSH). Ann N Y Acad Sci 2000; 917: 239.
19. Getting SJ. Melanocortin peptides and their receptors: New targets for anti-inflammatory therapy. Trends Pharmacol Sci 2002; 23: 447.
20. Gatti S, Colombo G, Buffa R, et al. α-Melanocyte stimulating-hormone protects the allograft in experimental heart transplantation. Transplantation 2002; 74: 1678.
21. Taylor AW. Ocular immunosuppressive microenvironment. Chem Immunol 1999; 73: 72.
22. Namba K, Kitaichi N, Nishida T, et al. Induction of regulatory T cells by the immunomodulating cytokines α-melanocyte stimulating hormone and transforming growth factor-β2. J Leukoc Biol 2002; 72: 946.
23. Naveh N, Marshall J. Melanocortins are comparable to corticosteroids as inhibitors of traumatic ocular inflammation in rabbits. Graefes Arch Clin Exp Ophthalmol 2001; 239: 840.
24. Shiratori K, Ohgami K, Illieva IB, et al. Inhibition of endotoxin-induced uveitis and potentiation of cyclooxygenase-2 protein expression by α-melanocyte-stimulating hormone. Invest Ophthalmol Vis Sci 2004; 45: 159.
25. Nishida T, Miyata S, Itoh Y, et al. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int Immunopharmacol 2004; 4: 1059.
26. Hamrah P, Zhang Q, Liu Y, et al. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci 2002; 43: 639.
27. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice-evidence that the immunogenic rules of rejection do not apply. Transplantation 1992; 54: 694.
28. Yamagami S, Hamrah P, Miyamoto K, et al. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the corneal epithelium. Invest Ophthalmol Vis Sci 2005; 46: 1201.
29. Liu Y, Hamrah P, Zhang Q, et al. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med 2002; 195: 259.
30. Chen L, Hamrah P, Cursiefen C, et al. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med 2004; 10: 813.
31. Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation 1997; 63: 1501.
32. Yamada J, Dana MR, Zhu SN, et al. Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation. Arch Ophthalmol 1998; 116: 1351.
33. Hamrah P, Yamagami S, Liu Y, et al. Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival. Invest Ophthalmol Vis Sci 2007; 48: 1228.
34. Qian Y, Boisgerault F, Benichou G, et al. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants. Invest Ophthalmol Vis Sci 2001; 42: 987.
35. Colombo G, Gatti S, Turcatti F, et al. Gene expression profiling reveals multiple protective influences of the peptide alpha-melanocyte-stimulating hormone in experimental heart transplantation. J Immunol 2005; 175: 3391.
36. + T cells are critical for corneal, but not skin, allograft rejection. Transplantation 2000; 69: 483.
37. Grabbe S, Bhardwaj RS, Mahnke K, et al. α-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 1996; 156: 473.
38. Qian Y, Dekaris I, Yamagami S, et al. Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants. Arch Ophthalmol 2000; 118: 1666.
39. Bhardwaj RS, Schwarz A, Becher E. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 1996; 156: 2517.
40. Luger TA, Scholzen TE, Brzoska T, et al. New insights into the function of α-MSH and related peptides in the immune system. Ann N Y Acad Sci 2003; 994: 133.
41. Manna SK, Aggarwal BB. α-Melanocyte-stimulating-hormone inhibits the nuclear transcription factor NF-κB activation induced by various inflammatory agents. J Immunol 1998; 161: 2873.
42. Catania A, Rajora N, Capsoni F, et al. The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 1999; 17: 675.
43. Rajora N, Ceriani G, Catania A, et al. α-MSH production, receptors, and influence on neopetrin in human monocytes/macrophage cell line. JAMA 1996; 59: 248.
44. Taylor AW. The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J Neuroimmunol 2005; 162: 43.
45. Kalden D-H, Fastrich M, Brzoska T, et al. Alpha-melanocyte-stimulating hormone reduces endotoxin-induced activation of nuclear NF-κB in endothelial cells. Ann N Y Acad Sci 1999; 885: 254.